Latest News & Features
Biotechnology
Novartis has signed a global licensing agreement with two biotechnology companies centring on the development of an antibody treatment for inflammatory skin conditions. 20 July 2018
Americas
Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers. 19 July 2018
Americas
Ropes & Gray has added Charlotte Jacobsen from Fitzpatrick, Cella, Harper & Scinto as a partner in the firm’s life sciences IP litigation practice. 19 July 2018
Americas
US-based law firm Cantor Colburn has hired Bryan Zerhusen as a partner and chair of the firm’s life sciences practice group. 19 July 2018
Americas
The US Food and Drug Administration is not going to play regulatory ‘whack-a-mole’ with companies trying to delay or derail the entry of biosimilar competitors, according to Scott Gottlieb, commissioner of the FDA. 19 July 2018
Americas
US-based biopharmaceutical company AbbVie entered into a patent licensing agreement with generics company Mylan yesterday. 18 July 2018
Americas
A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company. 18 July 2018
Americas
The US Court of Appeals for the Federal Circuit has rejected Jazz Pharmaceuticals’ attempt to revive patents covering its narcolepsy drug Xyrem. 17 July 2018
Americas
The US Court of Appeals for the Federal Circuit confirmed the validity of two patents covering a testosterone replacement therapy on Friday, July 13, in a win for Bayer Pharma and Endo Pharmaceuticals Solutions. 16 July 2018
Big Pharma
While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers. 16 July 2018